Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Bliss GVS Pharma Ltd.

Bliss GVS Pharma

₹ 0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
11 05 2021 Audited Results & Final Dividend
31 07 2021 Quarterly Results
30 10 2021 Quarterly Results
29 01 2022 Quarterly Results
30 04 2022 Final Dividend & Audited Results
07 11 2022 Quarterly Results
24 01 2023 Quarterly Results
11 05 2023 Audited Results & Final Dividend
01 08 2023 Quarterly Results
01 11 2023 Quarterly Results
23 01 2024 Quarterly Results
24 10 2024 Quarterly Results
28 01 2025 Quarterly Results
12 05 2025 Quarterly Results & Final Dividend & Audited Results
29 07 2025 Quarterly Results
06 11 2025 Quarterly Results
10 02 2026 Interim Dividend & Quarterly Results

News

26-NOV-2025

Bliss GVS Pharma’s arm incorporates wholly owned subsidiary in Kenya

The newly incorporated entity belongs to Pharmaceutical and Healthcare industry

09:58 AM
15-APR-2025

Bliss GVS Pharma’s marketing & distribution partner gets USFDA’s final approval for Mesalamine Suppositories

Rising Pharma Holdings has received final approval from USFDA for the product ‘Mesalamine Suppositories 1000 mg’

06:26 PM
15-JUN-2023

Bliss GVS Pharma gets EIR for Palghar manufacturing unit

Based on this inspection and the US FDA VAI classification, this facility is in compliance with regard to current good manufacturing practices

04:09 PM
20-MAR-2023

USFDA conducts inspections at Bliss GVS Pharma’s manufacturing unit in Palghar

After the inspection, the USFDA issued a Form 483 with 3 minor observations

11:59 AM
Enrich money logo